Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023

BUY
$35.33 - $55.79 $105 - $167
3 Added 0.03%
11,921 $665,000
Q4 2022

Feb 13, 2023

BUY
$24.4 - $41.3 $80,861 - $136,868
3,314 Added 38.52%
11,918 $434,000
Q3 2022

Nov 14, 2022

BUY
$28.48 - $52.59 $245,041 - $452,484
8,604 New
8,604 $246,000
Q2 2021

Aug 13, 2021

SELL
$134.22 - $202.37 $3.09 Million - $4.66 Million
-23,019 Closed
0 $0
Q1 2021

May 13, 2021

SELL
$140.25 - $196.86 $3.03 Million - $4.25 Million
-21,613 Reduced 48.42%
23,019 $4.17 Million
Q4 2020

Feb 10, 2021

BUY
$126.47 - $163.7 $5.64 Million - $7.31 Million
44,632 New
44,632 $6.32 Million

Others Institutions Holding TXG

About 10x Genomics, Inc.


  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $1.5B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track Martingale Asset Management L P Portfolio

Follow Martingale Asset Management L P and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Martingale Asset Management L P, based on Form 13F filings with the SEC.

News

Stay updated on Martingale Asset Management L P with notifications on news.